Pauline Campa Selected Research

Infections

1/2014	Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region.
1/2012	Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection.
1/2011	Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.
6/2009	Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients.
1/2006	Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection.
12/2003	Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort.
10/2002	Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pauline Campa Research Topics

Disease

7	Infections 01/2014 - 10/2002
4	HIV Infections (HIV Infection) 01/2016 - 04/2012
3	Lipodystrophy 01/2023 - 04/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 04/2015
2	Hepatitis B 01/2014 - 03/2013
2	Disease Progression 01/2013 - 12/2003
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2003 - 10/2002
1	Fibrosis (Cirrhosis) 01/2019
1	Inflammation (Inflammations) 04/2016
1	Diarrhea 08/2015
1	Latent Infection 08/2015
1	Insulin Resistance 04/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2015
1	Overweight 04/2015
1	Transverse Myelitis (Necrotizing Myelitis) 02/2014
1	Malaria 11/2013
1	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2013
1	Yellow Fever 04/2012

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 04/2012 - 10/2002
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2014 - 03/2013
1	EnzymesIBA 01/2023
1	Transaminases (Aminotransferases)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 04/2016
1	LactamsIBA 08/2015
1	Tuberculin (PPD)IBA 08/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2015
1	Anti-Idiotypic AntibodiesIBA 01/2014
1	proguanil drug combination atovaquone (malarone)FDA Link 11/2013
1	Lipopolysaccharide ReceptorsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013
1	VaccinesIBA 04/2012
1	Neutralizing AntibodiesIBA 04/2012
1	Interleukin-10 (Interleukin 10)IBA 01/2012
1	Raltegravir Potassium FDA Link 01/2011
1	Ritonavir (Norvir)FDA Link 06/2009
1	Lopinavir FDA Link 06/2009
1	InterleukinsIBA 01/2006
1	InterferonsIBA 01/2006
1	Viral RNAIBA 10/2002

Therapy/Procedure

5	Therapeutics 01/2019 - 12/2003
2	Art Therapy 04/2016 - 01/2016
1	Highly Active Antiretroviral Therapy (HAART) 06/2009